LIAISON®
Elastase-1
The first automated chemiluminescent assay for the determination of fecal pancreatic elastase, aiding in the diagnosis of exocrine pancreatic insufficiency.
Background
Treatment of maldigestion starts with the right diagnosis
Pancreatic insufficiency is the inability of the exocrine pancreas to produce and/or transport enough digestive enzymes to break down food in the intestine and facilitate absorption of nutrients. It typically occurs because of progressive pancreatic damage that may be caused by recurrent acute pancreatitis or by chronic pancreatitis due to a variety of conditions. Failure in any of the digestive metabolic steps may be the result in pancreatic exocrine insufficiency (PEI). Current methods for evaluating digestion, such as fecal fat quantification and the 13C-mixed triglycerides test are complicated and often need long execution times. LIAISON® Elastase-1, is a fully automated chemiluminescence (CLIA) assay that simplifies testing and reduces the number of required steps.
How it works
LIAISON® Elastase-1 is intended for the quantitative determination of fecal pancreatic elastase in human stool specimens.
Easy handling of stool sample
Easy handling of stool sample
The use of the LIAISON® Q.S.E.T. Device Plus reduces the preparation steps of the extracted stool samples and allows the operator to easily handle the stool, thus saving time.
30 minutes to results
Save time and unnecessary testing by quickly identifying exocrine pancreatic insufficiency (PEI).
Why use LIAISON® Elastase-1
A specific non-invasive method for PEI diagnosis
Reliable diagnostic solution
Safely diagnose PEI while preventing the patient from further invasive investigations.
Easy-to-use diagnostic solution
The LIAISON® Q.S.E.T. Device Plus is ready-to-use and improves the pre-analytical process. This tool offers a secure and simple handling of the feces.
Improved sensitivity and specificity
LIAISON® Elastase-1 has a better sensitivity and specificity than chymotrypsin testing (Doi: 10.3748/wjg.14.3149), and unlike other tests it is non-invasive and does not require patient to follow a special diet or discontinue pancreatic enzyme replacement therapy.
To be used on
Designed for both specialty and routine tests, LIAISON® XL and LIAISON® XS immunoassay analyzers help your laboratory handle multiple patients and tests simultaneously. LIAISON® systems are trustworthy, intuitive and deliver automated continuous operation with minimal user intervention. The result is reduced turnaround time, optimal cost management and unmatched growth potential.
LIAISON® XL
Designed for large laboratories. Combine the benefits of high throughput and high sensitivity within a powerful and fully automated system that can seamlessly connect to facilitate Total Laboratory Automation.
LIAISON® XS
A fully automated, easy-to-use benchtop analyzer. Maximize productivity with optimal cost management, no daily maintenance, straightforward integration, and the same capabilities as Diasorin’s high-throughput analyzers.
More details about our diagnostic solutions
Login to Dialog for additional resources
Login to our repository for instructions for use and user manuals, assay information, protocols and much more.